106 related articles for article (PubMed ID: 10714211)
1. [Reduction of acute kidney transplantation rejection by the chemokine receptor antagonist Met-RANTES].
Gröne HJ; Weber C; Weber KS; Gröne EF; Klier CM; Wells TN; Proudfoot AE; Schlöndorff D; Nelson PJ
Verh Dtsch Ges Pathol; 1999; 83():205-11. PubMed ID: 10714211
[TBL] [Abstract][Full Text] [Related]
2. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment.
Gröne HJ; Weber C; Weber KS; Gröne EF; Rabelink T; Klier CM; Wells TN; Proudfood AE; Schlöndorff D; Nelson PJ
FASEB J; 1999 Aug; 13(11):1371-83. PubMed ID: 10428761
[TBL] [Abstract][Full Text] [Related]
3. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection.
Yun JJ; Whiting D; Fischbein MP; Banerji A; Irie Y; Stein D; Fishbein MC; Proudfoot AE; Laks H; Berliner JA; Ardehali A
Circulation; 2004 Feb; 109(7):932-7. PubMed ID: 14757698
[TBL] [Abstract][Full Text] [Related]
4. Early application of Met-RANTES ameliorates chronic allograft nephropathy.
Song E; Zou H; Yao Y; Proudfoot A; Antus B; Liu S; Jens L; Heemann U
Kidney Int; 2002 Feb; 61(2):676-85. PubMed ID: 11849411
[TBL] [Abstract][Full Text] [Related]
5. Isotretinoin ameliorates renal damage in experimental acute renal allograft rejection.
Kiss E; Adams J; Gröne HJ; Wagner J
Transplantation; 2003 Aug; 76(3):480-9. PubMed ID: 12923432
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of chemokine receptor CCR2 and CCR5 expression contributes to simvastatin-induced attenuation of cardiac allograft vasculopathy.
Yin R; Zhu J; Shao H; Cheng X; Feng X; Li Z; Jing H
J Heart Lung Transplant; 2007 May; 26(5):485-93. PubMed ID: 17449418
[TBL] [Abstract][Full Text] [Related]
7. Role of RANTES in experimental cardiac allograft rejection.
Mulligan MS; McDuffie JE; Shanley TP; Guo RF; Vidya Sarma J; Warner RL; Ward PA
Exp Mol Pathol; 2000 Dec; 69(3):167-74. PubMed ID: 11115358
[TBL] [Abstract][Full Text] [Related]
8. Met-RANTES reduces endothelial progenitor cell homing to activated (glomerular) endothelium in vitro and in vivo.
Rookmaaker MB; Verhaar MC; de Boer HC; Goldschmeding R; Joles JA; Koomans HA; Gröne HJ; Rabelink TJ
Am J Physiol Renal Physiol; 2007 Aug; 293(2):F624-30. PubMed ID: 17567937
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of atorvastatin on chronic allograft nephropathy in rats.
Zhang W; Liu M; Wu Y; Zhu P; Yin C; Zhang W; Gu M
J Surg Res; 2007 Dec; 143(2):428-36. PubMed ID: 17628598
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral gene transfer of the chemokine antagonist RANTES 9-68 prolongs heart graft survival.
Vassalli G; Simeoni E; Li JP; Fleury S
Transplantation; 2006 Jan; 81(2):240-6. PubMed ID: 16436968
[TBL] [Abstract][Full Text] [Related]
11. Generation of GPI-linked CCL5 based chemokine receptor antagonists for the suppression of acute vascular damage during allograft transplantation.
Notohamiprodjo M; Djafarzadeh R; Mojaat A; von Lüttichau I; Gröne HJ; Nelson PJ
Protein Eng Des Sel; 2006 Jan; 19(1):27-35. PubMed ID: 16251221
[TBL] [Abstract][Full Text] [Related]
12. Treatment with Met-RANTES reduces lung injury in caerulein-induced pancreatitis.
Bhatia M; Proudfoot AE; Wells TN; Christmas S; Neoptolemos JP; Slavin J
Br J Surg; 2003 Jun; 90(6):698-704. PubMed ID: 12808617
[TBL] [Abstract][Full Text] [Related]
13. Met-RANTES inhibition of mucosal perfusion failure in acute intestinal transplant rejection - role of endothelial cell-leukocyte interaction.
Stojanovic T; Bedke J; Gröne HJ; Proudfoot AE; Becker H; Markus P; Hecker M
J Vasc Res; 2002; 39(1):51-8. PubMed ID: 11844937
[TBL] [Abstract][Full Text] [Related]
14. Gene transfer of RANTES and MCP-1 chemokine antagonists prolongs cardiac allograft survival.
Fleury S; Li J; Simeoni E; Fiorini E; von Segesser LK; Kappenberger L; Vassalli G
Gene Ther; 2006 Jul; 13(14):1104-9. PubMed ID: 16541117
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus accelerates chronic allograft nephropathy in a rat renal transplant model with associated provocative chemokine profiles.
Soule JL; Streblow DN; Andoh TF; Kreklywich CN; Orloff SL
Transplant Proc; 2006 Dec; 38(10):3214-20. PubMed ID: 17175227
[TBL] [Abstract][Full Text] [Related]
16. Induction of chronic renal allograft injury by injection of a monoclonal antibody against a donor MHC Ib molecule in a nude rat model.
Koch M; Broecker V; Heratizadeh A; Doege C; Strehlau J; Mengel M; Nashan B
Transpl Immunol; 2008 Jul; 19(3-4):187-91. PubMed ID: 18595711
[TBL] [Abstract][Full Text] [Related]
17. Chemokines and chemokine receptors in glomerulonephritis and renal allograft rejection.
Stasikowska O; Wagrowska-Danilewicz M
Med Sci Monit; 2007 Feb; 13(2):RA31-6. PubMed ID: 17261994
[TBL] [Abstract][Full Text] [Related]
18. Differential and additive effects of platelet-derived chemokines on monocyte arrest on inflamed endothelium under flow conditions.
Baltus T; von Hundelshausen P; Mause SF; Buhre W; Rossaint R; Weber C
J Leukoc Biol; 2005 Aug; 78(2):435-41. PubMed ID: 15899984
[TBL] [Abstract][Full Text] [Related]
19. PG490-88, a new immunosuppressant, effectively prevents acute and chronic rejection in rat renal allografts.
Pan F; Fisniku O; Wynn C; Erickson LM; Crews G; Jang MS; Sudo Y; Tamura K; Kobayashi M; Benediktsson H; Jiang H
Transplant Proc; 2005; 37(1):134-6. PubMed ID: 15808572
[TBL] [Abstract][Full Text] [Related]
20. Monocyte chemoattractant protein-1 and RANTES are chemotactic for graft infiltrating lymphocytes during acute lung allograft rejection.
Sekine Y; Yasufuku K; Heidler KM; Cummings OW; Van Rooijen N; Fujisawa T; Brown J; Wilkes DS
Am J Respir Cell Mol Biol; 2000 Dec; 23(6):719-26. PubMed ID: 11104723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
